NexImmune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NexImmune and other ETFs, options, and stocks.About NEXI
NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body's own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.
CEOKristi Jones
CEOKristi Jones
Employees6
Employees6
HeadquartersGaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded2011
Founded2011
Employees6
Employees6
NEXI Key Statistics
Market cap4.51M
Market cap4.51M
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume19.42K
Average volume19.42K
High today$3.59
High today$3.59
Low today$3.26
Low today$3.26
Open price$3.29
Open price$3.29
Volume7.32K
Volume7.32K
52 Week high$28.69
52 Week high$28.69
52 Week low$0.15
52 Week low$0.15